The final analysis of a multicenter randomized controlled trial of gemcitabine (G) alone versus gemcitabine and S-1 combination therapy (GS) in patients with unresectable advanced pancreatic cancer (PC): GEMSAP study.
2011 ◽
Vol 29
(15_suppl)
◽
pp. 4040-4040
◽
2010 ◽
Vol 28
(15_suppl)
◽
pp. 4037-4037
◽
2011 ◽
Vol 39
(6)
◽
pp. 511-515
◽
2004 ◽
Vol 22
(14_suppl)
◽
pp. 4131-4131
◽
2004 ◽
Vol 22
(14_suppl)
◽
pp. 4131-4131
◽